Status:
RECRUITING
Right Tools, Right Time, Right Place: Telehealth for Opioid Use Disorder in Vulnerable Settings
Lead Sponsor:
Boulder Care
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Opioid Use Disorder
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
Our primary objective is to evaluate the ability of Boulder Care's telehealth-platform to create the necessary paradigmatic shift in Opioid Use Disorder (OUD) treatment to reach vulnerable populations...
Eligibility Criteria
Inclusion
- History of Opioid Use Disorder (OUD)
- Starting OUD treatment with buprenorphine, or within 45 days of starting or restarting this medication
- Speak and understand English
Exclusion
- History of allergic reaction to buprenorphine
- Plans to move out of a Boulder Care-affiliated state site in the next 12 months (precluding continuation of care)
- Untreated mental or medical health conditions that, in the opinion of the participant, would preclude study participation
Key Trial Info
Start Date :
June 10 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 15 2027
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT07169409
Start Date
June 10 2025
End Date
September 15 2027
Last Update
September 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boulder Care
Portland, Oregon, United States, 97204